Drug Type Small molecule drug |
Synonyms (−)-pironetin, PA-48153C/CMPul conjugates, pironetin + [3] |
Target |
Mechanism alpha-tubulin inhibitors(Tubulin alpha inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC19H32O4 |
InChIKeyXIHGDBYGUWEHCV-FSEPSNHWSA-N |
CAS Registry151519-02-7 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Arthritis | Phase 3 | JP | - | |
Autoimmune Diseases | Phase 3 | JP | - | |
Neoplasms | Preclinical | US | 01 May 2007 |